...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers
【24h】

Water-soluble prodrugs of paclitaxel containing self-immolative disulfide linkers

机译:含紫杉醇自消灭性二硫键的紫杉醇水溶性前药

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A new series of disulfide-containing prodrugs of paclitaxel were designed, synthesized and evaluated against 6 cancer cell lines. Some of these prodrugs exhibited nearly equal or slightly better anticancer activity when compared to that of paclitaxel. These prodrugs contain water-soluble groups such as amino, carboxyl, hydroxyl, amino acids, etc., and exhibited 6-140 fold increase in aqueous solubility when compared to paclitaxel. One of these prodrugs exhibited improved water solubility, better in vitro anticancer activity and significantly superior oral bioavailability in mice when compared to those of paclitaxel. Thus, we have identified a very promising lead compound for further optimization and evaluation as a potentially bioavailable water-soluble prodrug of paclitaxel. (C) 2014 Elsevier Ltd. All rights reserved.
机译:设计,合成并评估了针对6种癌细胞系的一系列新的含紫杉醇二硫键的前药。与紫杉醇相比,这些前药中的一些显示出几乎相同或稍好的抗癌活性。这些前药含有水溶性基团,例如氨基,羧基,羟基,氨基酸等,并且与紫杉醇相比,其水溶性增加了6-140倍。与紫杉醇相比,这些前药之一在小鼠中表现出改善的水溶性,更好的体外抗癌活性和明显优越的口服生物利用度。因此,我们已经鉴定出非常有前途的铅化合物,可以进一步优化和评估,作为潜在的生物可利用的紫杉醇水溶性前药。 (C)2014 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号